Alice Di Rocco


Titolo Pubblicato in Anno
Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma BONE MARROW TRANSPLANTATION 2024
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study LEUKEMIA 2024
Whole body MRI with Difusion Weighted Imaging versus 18F‑fuorodeoxyglucose‑PET/CT in the staging of lymphomas LA RADIOLOGIA MEDICA 2023
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia CANCERS 2023
Long term follow-up of Rituximab plus Bendamustine and Cytarabine (R-BAC) in elderly patients with newly diagnosed MCL BLOOD ADVANCES 2023
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas LA RADIOLOGIA MEDICA 2023
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the FIL MCL0208 trial BLOOD ADVANCES 2023
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi BRITISH JOURNAL OF HAEMATOLOGY 2023
Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations HEMATOLOGICAL ONCOLOGY 2023
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study JOURNAL OF CLINICAL MEDICINE 2023
Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity? ANNALS OF HEMATOLOGY 2023
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS FRONTIERS IN ONCOLOGY 2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy ANNALS OF HEMATOLOGY 2023
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic BONE MARROW TRANSPLANTATION 2023
Outcome after chimeric antigen receptor (CAR) T-cell therapy failure in large B-cell lymphomas BRITISH JOURNAL OF HAEMATOLOGY 2023
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma BLOOD ADVANCES 2023
Bing-Neel syndrome coexisting with oligodendroglioma LEUKEMIA & LYMPHOMA 2022
Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL) LEUKEMIA & LYMPHOMA 2022
Donor cell derived mantle cell lymphoma in a HSCT sibling donor-recipient pair: intrinsic biological clock in lymphomagenesis LEUKEMIA & LYMPHOMA 2022
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases HEMATOLOGICAL ONCOLOGY 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma